Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease.

Flesh extract showed an increasing trend as the dosing concentration increased from 4.46 μg/mL to 142.86 μg/mL, particularly when the cells were stimulated with MDP, but no significant difference was observed relative to the control.

also in 63,971 other papers